BioNxt Solutions IncCanadian Securities Exchange:BNXTView on OTCQB
- LAST PRICE0.4000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.3250/ 2
- Ask / Lots0.4300/ 40
- Open / Previous Close0.0000 / 0.4000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Apr 25, 2024
Bionxt Solutions Announces Odf Cladribine Update and Financing, from 11:50PM ET on Thursday Apr 25, 2024 by Dow Jones
11:50PM ET on Thursday Apr 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioNxt Solutions Inc | 43.8M | -5.2x | --- |
LSL Pharma Group Inc | 43.3M | 0.0x | --- |
Medicus Pharma Ltd | 36.3M | -2.2x | --- |
Devonian Health Group Inc | 32.6M | -7.2x | --- |
Pharmather Holdings Ltd | 22.0M | -5.4x | --- |
Nextleaf Solutions Ltd | 22.5M | 26.1x | --- |
Company Information
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. The Company, through its subsidiary, 3a-diagnostics GmbH, offers diagnostic products, which include COVID-19 PCR Diagnostic Kit and Peri-Implantitis Oral Biosensor.
Contact Information
- Headquarters
- Suite 270 - 1820 Fir StreetVANCOUVER, BC, Canada V6J 3B1
- Phone
- 780-818-6422
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $43.8M |
|---|---|
Revenue (TTM) | $372.3K |
Shares Outstanding | 109.5M |
BioNxt Solutions Inc does not pay a dividend. | |
Beta | 0.56 |
EPS | $-0.08 |
Book Value | $-0.05 |
P/E Ratio | -5.2x |
Price/Sales (TTM) | 117.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,768.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
